For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...
Praxis Precision Medicines (PRAX) on Tuesday announced an accelerated timeline in the development of its anti-seizure therapy, relutrigine, following positive feedback from the U.S. FDA. The Boston, ...
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...
In today’s Health Headlines, can treatment-resistant epilepsy improve over time? Are melatonin supplements bad for your heart? And what resources are available for people who rely on emergency rooms ...
Focal treatment-resistant epilepsy improves over time, but seizure reduction appears to be unrelated to specific medications ...
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn’t stop seizures for everyone and ...
EMA’s PRIME designation bolsters Neurona’s global development strategy and underscores the company’s commitment to bringing NRTX-1001 interneuron cell therapy to patients worldwide.
Magnetic seizure therapy (MST) offers similar efficacy as electroconvulsive therapy (ECT) in treating bipolar mania in adults, with significantly fewer adverse effects on language abilities, new ...
A new form of gene therapy designed to treat the most treatment-resistant form of childhood epilepsy appears to reduce seizures in mice. In a research article published Dec. 14 in Brain, researchers ...
"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults ...
Scientists from Laval University and the University of Texas Southwestern Medical Center have joined forces to understand ...